TickerFacts.

Opko Health, Inc. (OPK): Share Repurchases

Annual figures by period end, from SEC filings.

$47.04M
Year ended 2025-12-31
$46.57M
Trailing 12 months to 2026-06-30
$90.22M2011-12-31: $7.83M2012-12-31: $02013-12-31: $02022-12-31: $02023-12-31: $02024-12-31: $90.22M2025-12-31: $47.04M$47.04M
2011-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$47.04M-47.9%2026-02-26, From 2025-01-01
2024-12-31$90.22Mn/a2026-02-26, From 2024-01-01
2023-12-31$0n/a2026-02-26, From 2023-01-01
2022-12-31$0n/a2025-03-03, From 2022-01-01
No annual figure between 2013-12-31 and 2022-12-31.
2013-12-31$0n/a2014-03-03, From 2013-01-01
2012-12-31$0-100.0%2014-03-03, From 2012-01-01
2011-12-31$7.83Mn/a2014-03-03, From 2011-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Opko Health, Inc. (OPK)2025-12-31$47.04M-47.9%
Organogenesis Holdings Inc. (ORGO)2024-12-31$25.48Mn/a
HUTCHMED (China) Ltd (HCM)2024-12-31$36.06M+297.6%
Amphastar Pharmaceuticals, Inc. (AMPH)2025-12-31$75.59M-11.6%
Pacira BioSciences, Inc. (PCRX)2025-12-31$148.33M+493.3%
BridgeBio Pharma, Inc. (BBIO)2025-12-31$48.28Mn/a
Emergent BioSolutions Inc. (EBS)2025-12-31$24.90Mn/a
Corcept Therapeutics Inc (CORT)2025-12-31$172.91Mn/m
Nature's Sunshine Products Inc (NATR)2025-12-31$16.31M+84.1%

Compare OPK, ORGO, HCM, AMPH side by side · Screen every company in Pharmaceutical Preparations ↗